Form 4 for INM InMed Pharmaceuticals Inc.
Accepted 2021-12-30 00:00:00 ET · period of report 2021-12-30 · accession 0001213900-21-068212 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-30 | 2021-12-30 | INM | Johnson Shane Aaron | SVP, GM of BayMedica LLC | P - Purchase | $1.33 | +8,093 | 296.1K | +3% | +$10.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-30 | P | A | 8,093 | $1.33 | 296,095 | D | — | — |